We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

80 hedge funds and large institutions have $93.4M invested in Abeona Therapeutics in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 22

10% more call options, than puts

Call options by funds: $215K | Put options by funds: $196K

0.51% less ownership

Funds ownership: 2.64% → 2.13% (-0.51%)

8% less funds holding

Funds holding: 87 → 80 (-7)

35% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 20

48% less capital invested

Capital invested by funds: $180M → $93.4M (-$86.5M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
80
Holders Change
-7
Holders Change %
-8.05%
% of All Funds
1.76%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
13
Increased
32
Reduced
22
Closed
20
Calls
$215K
Puts
$196K
Net Calls
+$19K
Net Calls Change
-$1.07M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.15M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.58M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.34M
4
WP
Woodline Partners
California
+$1.1M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.03M

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$17.1M
2
FCM
Farallon Capital Management
California
-$6.54M
3
Millennium Management
Millennium Management
New York
-$5.04M
4
SSA
Schonfeld Strategic Advisors
New York
-$4.76M
5
APM
Avidity Partners Management
Texas
-$4.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
Nisa Investment Advisors
76
Nisa Investment Advisors
Missouri
$3K +$3.47K +52 New
EWM
77
Endurance Wealth Management
Rhode Island
$1K – – –
EI
78
Ellevest Inc
New York
$1K +$868 +13 New
TRCT
79
Tower Research Capital (TRC)
New York
$1K +$1.4K +21 New
CH
80
CVI Holdings
Delaware
– -$17.1M -209,095 Closed
FCM
81
Farallon Capital Management
California
– -$6.54M -80,000 Closed
SSA
82
Schonfeld Strategic Advisors
New York
– -$4.76M -58,268 Closed
APM
83
Avidity Partners Management
Texas
– -$4.33M -53,000 Closed
SFM
84
Sphera Funds Management
Israel
– -$2.36M -28,819 Closed
MWNA
85
Marshall Wace North America
New York
– -$1.62M -19,772 Closed
SCM
86
Sio Capital Management
New York
– -$924K -11,301 Closed
WG
87
Winton Group
United Kingdom
– -$671K -8,209 Closed
OAM
88
Oxford Asset Management
United Kingdom
– -$400K -4,888 Closed
MS
89
Maven Securities
Jersey
– -$255K -3,000 Closed
BGIM
90
Brandywine Global Investment Management
Pennsylvania
– -$197K -2,448 Closed
SM
91
Sabby Management
Florida
– -$197K -2,414 Closed
CM
92
Caption Management
Oklahoma
– -$130K -1,600 Closed
HF
93
HRT Financial
New York
– -$91K -1,116 Closed
ZCM
94
Zebra Capital Management
Connecticut
– -$50K -607 Closed
PHK
95
Point72 Hong Kong
Hong Kong
– -$34K -410 Closed
ARTA
96
A.R.T. Advisors
New York
– -$33K -404 Closed
BFM
97
Boothbay Fund Management
New York
– -$33K -400 Closed
LC
98
Lindbrook Capital
California
– -$13K -160 Closed
CG
99
Cutler Group
California
– -$3K -40 Closed
1 2 3
4

ABEO Hedge Fund Activity: Q1 2020 in Review

80 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2020, worth a combined $93.4M — down 48% from $180M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ABEO and 13 opened new positions — a net loss of 7 holders — while 22 trimmed existing stakes and 32 added.

The largest buyer was BlackRock, adding an estimated $3.15M. The largest seller was CVI Holdings, exiting entirely with an estimated $17.1M sold.

  • 80 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2020, down from 87 in Q4 2019.
  • Funds reported $93.4M of Abeona Therapeutics stock for Q1 2020, down 48% quarter-over-quarter.
  • 13 funds opened new Abeona Therapeutics positions in Q1 2020 and 20 closed out, a net change of -7 holders.
  • The largest Abeona Therapeutics buyer in Q1 2020 was BlackRock, an estimated $3.15M added.
  • The largest Abeona Therapeutics seller in Q1 2020 was CVI Holdings, an estimated $17.1M sold.

Based on aggregated 13F filings for Q1 2020.